BACKGROUND: Hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome is associated with a high risk of serious maternal and neonatal morbidity and mortality. To date, termination of the pregnancy has been the appropriate treatment for this syndrome. However, long-term administration of corticosteroids is becoming increasingly popular for the treatment of HELLP syndrome. CASE REPORT: A 32-year-old primigravida was admitted to our hospital with HELLP syndrome in the 23rd week of gestation. The patient received corticosteroids for about six weeks. We achieved a successful prolongation of the patient's pregnancy until the 29th week of gestation. CONCLUSION: This case report supports the use of long-term corticosteriod administration for successful prolongation of a pregnancy in a patient with HELLP syndrome during early pregnancy.
|Translated title of the contribution||Long-term corticosteroid treatment of a patient with preeclampsia and HELLP syndrome in mid-pregnancy|
|Journal||Geburtshilfe und Frauenheilkunde|
|Number of pages||4|
|Publication status||Published - 2009|
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)